跳至主要内容
临床试验/NL-OMON32278
NL-OMON32278撤回不适用

Identifying novel biomarkers in left ventricular hypertrophy patients - Biomarkers in left ventricular hypertrophy

Academisch Medisch Centrum0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Patients are included in this study when planned for surgical aortic valve replacement for severe aortic valve stenosis. Signs of left ventricular hypertrophy have to be present either on ECG, echocardiography or MRI. None of the exclusion criteria are met. Written informed consent is obtained.

排除标准

  • Patients with concomitant heart disease: previous myocardial infarction, endocarditis. Patients younger than 18 years of age are also excluded from participation in this study. Patients who have a syndromic or genetic diagnosis, for example, Marfan*s disease, trisomy 21, and Turner*s syndrome

研究者

相似试验

Identifying novel biomarkers in left ventricular... | 临床试验